Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice.
Journal: Blood advances
Published: October 29, 2020
Corrigendum to 'Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)' The American Journal of Cardiology 119 (2017) 1576-1583.
Journal: The American journal of cardiology
Published: December 20, 2017
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: April 14, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study).
Journal: The American journal of cardiology
Published: November 11, 2016
A phase 1 study to evaluate the safety and LDL cholesterol-lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9.
Journal: Clinical cardiology
Published: November 07, 2016
Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 08, 2016
Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.
Journal: Journal of clinical pharmacology
Published: July 29, 2015
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE.
Journal: Lupus science & medicine
Published: December 23, 2014
Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis.
Journal: Journal of autoimmunity
Published: November 27, 2014
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Journal: Annals of the rheumatic diseases
Published: June 13, 2014
Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study).
Journal: Arthritis research & therapy
Published: June 03, 2014
Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's).
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 07, 2013
Last Updated: 09/26/2026